Capillary permeability and platelet survival studies in hematologic patients with vascular fragility.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000756:Anemia, Sideroblastic / Q000097:blood; D001161:Arteriosclerosis / Q000097:blood; D001772:Blood Cell Count; D001792:Blood Platelets; D002199:Capillary Permeability; D006333:Heart Failure / Q000150:complications; D006402:Hematologic Diseases / Q000097:blood* / Q000188:drug therapy; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D007945:Leukemia, Lymphoid / Q000097:blood; D007951:Leukemia, Myeloid / Q000097:blood; D008103:Liver Cirrhosis / Q000150:complications; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood; D009101:Multiple Myeloma / Q000097:blood; D010759:Phosphorus Isotopes; D011696:Purpura, Thrombocytopenic / Q000097:blood; D012711:Serum Albumin, Radio-Iodinated; D014511:Uremia / Q000097:blood
D000305:Adrenal Cortex Hormones; D010759:Phosphorus Isotopes; D012711:Serum Albumin, Radio-Iodinated